Appalachian Center for Cellular transport in Obesity Related Disorders (ACCORD) Marshall University Imaging Core
Appalachian Center for Cellular transport in Obesity Related Disorders (ACCORD) Marshall University Imaging Core
批准号:
10460404
负责人:
Michael Louis Norton
金额:
$8.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-02-15 至 2025-01-31
关键词:
AddressAffectAppalachian RegionAtomic Force MicroscopyAwardBinding ProteinsBiological ModelsBiomedical ResearchCellsCenters of Research ExcellenceCommunitiesComplexConsultCuesCustomDevelopmentDiseaseElectronsElementsEnergy TransferEvolutionExperimental DesignsFluorescenceFluorescence Recovery After PhotobleachingFluorescence Resonance Energy TransferFoundationsFundingFutureGenerationsGoalsGrowthHealthHypertensionImageImage AnalysisImaging DeviceImaging TechniquesImaging technologyIndividualInstitutesInterdisciplinary StudyKineticsLettersMalignant NeoplasmsManuscriptsMethodsMolecularMonitorObesityObesity associated diseaseOpticsPharmacologyPhysiologicalPopulationPreparationProcessProductionProteinsPublicationsResearchResearch PersonnelResearch SupportResolutionResourcesRoleSamplingScanning Probe MicroscopyScienceSectioning techniqueServicesSignal TransductionSpecialistSpeedSystemTalentsTechniquesTestingThree-Dimensional ImagingTissuesTrainingUniversitiesUse of New TechniquesVisualizationVisualization softwareWest Virginiacellular imagingdesignexpectationexperimental studyfluorescence imagingfluorescence microscopeimaging capabilitiesimaging systeminstrumentationlive cell imagingmalformationoptical imagingprotein transportresponsesingle moleculeskeletaltool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Marshall University Imaging Core will support the imaging activities of five junior investigators and
potential pilot investigators as part of the project titled "Appalachian Center for Cellular transport in
Obesity Related Disorders (ACCORD)". The five junior investigators have identified abnormalities in
cellular transport related to disease states which are particularly associated with obesity, including
cancer, hypertension and skeletal malformations. With the long-range goal of minimizing the health
impact of dysregulated transport, or even blocking or reversing processes related to these transport
mechanisms, these researchers seek to develop molecular level descriptions, which will lead to an
understanding of the transport mechanism and the mechanism by which external factors can affect
transport. The Imaging Core will support the long-range goals of these investigators by providing
visualization tools and techniques which will enable them to determine the relative numbers and
distributions of the specific proteins they have determined are associated with transport anomalies in
selected disease states. The principle imaging tool which will be applied for the visualization tasks is a
Multiphoton Fluorescence Microscope, which will enable high resolution optical imaging of tagged
proteins. The multiphoton capability increases the quality of optical imaging in tissue, and will be used in
studies comparing normal and abnormal tissues. This imaging capability will be enhanced, for
researchers developing suitable model systems, via the production of custom tagged proteins suitable for
use in live cell imaging. Live cell imaging will provide the opportunity to observe changes in protein
concentrations and/or distributions within a cell occurring in response to a physiologically relevant cue or
resulting from introduction of a pharmacological agent. Techniques enabled by fluorescent protein
tagging, including FRET (fluorescence resonant energy transfer) and FRAP (fluorescence recovery after
photobleaching) may be employed to test developing hypotheses of protein transport mechanisms and
their anomalies. Additional capabilities, including single molecule fluorescence imaging and atomic force
microscopy will be available for addressing evolving project requirements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金